Clinical Trial Update: The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Traditional Chinese Medicine for childhood chronic immune thrombocytopenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Childhood Chronic Immune Thrombocytopenia | Phase 2, Phase 3 | Status: TERMINATED